A specific lot of blood pressure medication has been recalled after a bottle from that lot was found to be mislabeled. The FDA says that the effects of this error range from "limited" to "life-threatening." The bottle was supposed to contain Hydrochlorothiazide Tablets — a medication used to treat high blood pressure. Instead, they contained Spironolactone Tablets USP 25 mg — used to treat congestive heart failure, cirrhosis of the liver and other ailments.The FDA says that the effects of mixing up the medications depends on the individual. The FDA recommends checking with a pharmacy or healthcare provider.The FDA says there have been no reports of adverse incidents relating to this recall